SEC Form 4
Ardent Health, Inc. (ARDT) insider trading
In the 12 months to Oct 26, 2026, 2 ARDT insiders reported open-market purchases of $186.4K across 2 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $186.4K
- 2 filings
Who traded ARDT, and when
- Purchase
ARDT daily close from Oct 27, 2025 to Oct 26, 2026, between $7.83 and $15.14, last $12.29. 0 sale and 2 purchase filings by 2 insiders, marked at their filing dates. Robert DeMichiei, Director: bought $98.3K across 1 filing, first filed Jun 8, 2026, last Jun 8, 2026. Alfred Lumsdaine, Chief Financial Officer: bought $88.1K across 1 filing, first filed Jun 8, 2026, last Jun 8, 2026.
Largest mark · tap a row for others
Robert DeMichiei · Director
Purchase $98,300
11,260 shares at $8.73 avg
Filed Jun 8, 2026 · traded Jun 5
Close on filing date $8.83
Robert DeMichiei · Director
Director
$98.3K boughtAlfred Lumsdaine · Chief Financial Officer
Chief Financial Officer
$88.1K boughtOpen-market trades
2 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Robert DeMichiei | Director | — | $98.3K | 1 | — | |
| Alfred Lumsdaine | Chief Financial Officer | — | $88.1K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Alfred Lumsdaine Chief Financial Officer | Purchase | 10,000 | $8.81 | $88.1K | 329,183 | |
traded | Robert DeMichiei Director | Purchase | 11,260 | $8.73 | $98.3K | 35,564 |
GET /stocks/filings/vX/form-4?tickers=ARDT&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"ARDT"
],
"issuer_cik": "0001756655",
"owner_cik": "0001928634",
"accession_number": "0001628280-26-041445",
"form_type": "4",
"filing_date": "2026-06-08",
"period_of_report": "2026-06-05",
"issuer_name": "Ardent Health, Inc.",
"issuer_trading_symbol": "ARDT",
"owner_name": "DeMichiei Robert",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-06-05",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 11260,
"transaction_price_per_share": 8.73,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 35564,
"transaction_value": 98299.8,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported in Column 4 is a weighted average price of $8.73 per share. These shares were purchased in multiple transactions on 06/05/26 at prices ranging from $8.60 to $8.78, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."
}
]
},
{
"tickers": [
"ARDT"
],
"issuer_cik": "0001756655",
"owner_cik": "0001188873",
"accession_number": "0001628280-26-041444",
"form_type": "4",
"filing_date": "2026-06-08",
"period_of_report": "2026-06-05",
"issuer_name": "Ardent Health, Inc.",
"issuer_trading_symbol": "ARDT",
"owner_name": "LUMSDAINE ALFRED",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Financial Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-06-05",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 10000,
"transaction_price_per_share": 8.81,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 329183,
"transaction_value": 88100,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 33 records
- Tax withholding12 records
- Grants and awards21 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Ardent Health, Inc.'s CEO sold stock?
No. Dave Caspers and Martin Bonick (CEOs) made no open-market sales filed as CEO in the last 12 months.
How current is ARDT’s insider data?
These are ARDT Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track ARDT insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for ARDT every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.